Literature DB >> 22399

Possible sites of origin of human plasma ribonucleases as evidenced by isolation and partial characterization of ribonucleases from several human tissues.

E A Neuwelt, M S Boguski, J J Frank, K Procter-Appich, C C Levy.   

Abstract

The ribonucleases (RNases) present in a number of human tissues, including heart, brain, lung, and kidney, were purified, partially characterized, and compared in their properties to the previously described RNases from human liver, spleen, pancreas, and serum. The enzymes appeared to fall into two major classes: liver-spleen type RNase and plasma-type RNase. These two types of enzymes were present in varying proportions in all tissues examined. The extent to which the tissues studied possibly contribute to serum RNase levels is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 22399

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Serum ribonuclease activity in the diagnosis of pancreatic disease.

Authors:  T P Kemmer; P Malfertheiner; M Büchler; M L Kemmer; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1991-01

2.  Long-term storage of endocrine tissues at - 80°C does not adversely affect RNA quality or overall histomorphology.

Authors:  Adam Andreasson; Nimrod B Kiss; C Christofer Juhlin; Anders Höög
Journal:  Biopreserv Biobank       Date:  2013-12       Impact factor: 2.300

3.  Ribonuclease as a tumour marker for pancreatic carcinoma.

Authors:  G Doran; T G Allen-Mersh; K W Reynolds
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

4.  Serum alkaline ribonuclease derived from vascular endothelial cells is raised in patients with rheumatoid vasculitis.

Authors:  M Oribe; M Shingu; M Nobunaga
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

5.  Cell type-specific mRNA purification by translating ribosome affinity purification (TRAP).

Authors:  Myriam Heiman; Ruth Kulicke; Robert J Fenster; Paul Greengard; Nathaniel Heintz
Journal:  Nat Protoc       Date:  2014-05-08       Impact factor: 13.491

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.